Beau Bosko Toskich, Interventional Radiologist at Mayo Clinic, shared a post on X:
“A multidisciplinary and comprehensive review of combination Y90 and Immunotherapy for HCC.
ROWAN and EMERALD Y90 clinical trials are investigating these therapies with current practice.”
